Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

The Complete Guide to Transcranial Magnetic Stimulation - Arcara Personalized Psychiatry


News provided by

Arcara Personalized Psychiatry

Dec 27, 2022, 11:40 ET

Share this article

Share toX

Share this article

Share toX


Complete guide to TMS (Transcranial Magnetic Stimulation)

BOSTON, Dec. 27, 2022 /PRNewswire-PRWeb/ -- What is Transcranial Magnetic Stimulation (TMS)?

To stimulate brain cells, scientists developed a technique called Transcranial Magnetic Stimulation (TMS), which relies on magnetic fields rather than electrical currents. The Food and Drug Administration (FDA) has given its stamp of approval to this non-invasive treatment for depression, and it is currently being researched for a wide variety of other psychiatric and neurological disorders.

TMS was found to be as effective as antidepressant drugs and to have a comparable response rate.

Post this

What is the function of Transcranial Magnetic Stimulation?

A coil placed against the scalp delivers magnetic pulses to particular regions of the brain via TMS. These pulses produce an electric current in the brain, which can activate nerve cells and affect brain function. It is not completely understood how TMS causes its effects, although it is believed to entail changes in the levels of neurotransmitters such as serotonin and dopamine.

Transcranial Magnetic Stimulation is a sequence of treatments

Typically, TMS is provided in a series of sessions, with each session lasting between 20 and 40 minutes. The majority of patients receive TMS therapy five days per week for four to six weeks, although the particular treatment regimen depends on the patient and the disease being treated. TMS is generally well tolerated, with few significant side effects. The most common side effects are scalp soreness and mild headache, both of which are treatable with over-the-counter medication.

Transcranial Magnetic Stimulation (TMS) treatment for depression has been the subject of substantial research and has been demonstrated to reduce symptoms in many patients. In clinical trials, TMS was found to be as effective as antidepressant drugs and to have a comparable response rate. However, for certain patients, TMS may be preferable because it is non-invasive and does not have the same adverse effects as antidepressant medication.

Can TMS be used to treat other psychiatric conditions?

TMS is currently being investigated as a potential treatment for a wide variety of psychiatric conditions, including but not limited to anxiety disorders, bipolar disorder, and post-traumatic stress disorder (PTSD). In certain cases, Transcranial Magnetic Stimulation (TMS) has been shown to be effective in alleviating the symptoms of a variety of diseases; nevertheless, further investigation is necessary to fully appreciate the scope of its possible benefits.

TMS is not a miracle cure, and it may not be effective for everyone who tries it. Before beginning treatment, it is critical to discuss the potential benefits and drawbacks of Transcranial Magnetic Stimulation (TMS) with a qualified medical professional. A comprehensive evaluation, which must include both a review of the patient's medical history and an evaluation of the patient's mental state, is necessary in order to determine whether or not TMS is an acceptable treatment for a specific person.

Find a qualified TMS practitioner:

After performing an extensive study on the many TMS options available to you, the next step is to seek TMS providers who are certified and have prior experience administering TMS. These service providers must be reliable, credible, and qualified.

Consider a psychiatrist or neurologist who is licensed to practice medicine and has obtained specialized training in TMS. Finding a physician who can help you develop individualized treatment plans and provide ongoing support is also essential if you want the best potential treatment outcome.

Examining the top 5 benefits of TMS:

  • Noninvasive: TMS operates externally. No operation or electrodes are required. During a diagnosis or therapy session, the TMS machine emits a small electromagnetic pulse into the brain to stimulate the release of serotonin and dopamine by mood-regulating cells. Similar to MRI waves, these waves are harmless and non-painful.
  • TMS side effects are mild: TMS has no lasting or severe side effects, unlike common depression and anxiety medications. Antidepressants can cause nausea, weight gain, weariness, sleeplessness, sexual dysfunction, memory loss, and apathy.
  • TMS requires neither sedation or anesthesia: TMS therapy can be administered in an outpatient clinic or hospital setting. There are no adverse effects, and patients do not need to be accompanied and they can drive themselves home after treatment.
  • TMS is not habit-forming: Some medication therapies for depression and mental disorders pose an addiction risk. TMS however, is completely non-addictive and has been shown to be beneficial in treating substance use disorder, as well as other co-occurring problems such as PTSD and bipolar disorder.
  • Long-term benefits and efficacy of TMS: Research has demonstrated that TMS can be as successful as talk therapy for some mental health problems (up to 70% effective), with benefits lasting for months after treatment has ended (up to 90% of participants still report feeling better 12 months after TMS treatment ended). As an added bonus, it has shown excellent results in individuals who did not initially respond well to antidepressant drugs.

Explore your TMS options with Arcara

Is finding the correct facility to meet your mental health requirements a priority for you? Arcara provides a safe environment for clients to ask pertinent questions when conducting research, contemplating beginning the treatment, or having exhausted all available options and being prepared to embark on their path.

Arcara Personalized Psychiatry utilizes TMS from NeuroStar. Their machine is regarded as one of the greatest in the industry. It is non-invasive and user-friendly. Patients will not need to wear a helmet since NeuroStar employs a handheld device that is smaller and more controllable. This equipment is used by the physician to provide electromagnetic pulses for the treatment. NeuroStar TMS treatments are efficient and simple.

In conclusion, Transcranial Magnetic Stimulation is a viable choice for treating depression and other mental health issues because it is both safe and effective. TMS is an intriguing and promising therapy that can provide patients with treatment-resistant depression with real and enduring relief.

TMS is an outpatient procedure that does not include any intrusive procedures and is generally well-tolerated and safe. This allows patients to receive treatment without interfering with their daily activities. TMS has a similarly bright future, with studies examining its broader applications and use as a maintenance treatment.

Media Contact

Kimberley Arcara, Arcara Personalized Psychiatry, 1 (617) 431-6140, [email protected]

SOURCE Arcara Personalized Psychiatry

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.